
TB-500 (also known as TB4, a synthetic fragment of the naturally occurring protein thymosin beta-4) is a research peptide studied for its potential roles in promoting cell migration, angiogenesis, and tissue repair; however, it is not an approved drug, and its safety, efficacy, and proper dosing in humans have not been clinically validated, limiting its use strictly to experimental research settings.